Article Details

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride ... - Taiwan News

Retrieved on: 2025-02-04 14:14:23

Tags for this article:

Click the tags to see associated articles and topics

Supernus Announces FDA Approval of ONAPGO™ (apomorphine hydrochloride ... - Taiwan News. View article details on hiswai:

Summary

The article details Supernus Pharmaceuticals' ONAPGO, a subcutaneous apomorphine device for advanced Parkinson’s disease, emphasizing its advantages over levodopa. Tags highlight its relation to CNS treatments, dopamine agonists, and relevant stakeholders, excluding Zeiss.

Article found on: www.taiwannews.com.tw

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up